Report Library
View More
HR+/HER2- Breast Cancer KOL Intervi...
November 6, 2024
HR+/HER2- Breast Cancer KOL Intervi...
November 6, 2024
HER2+ Breast Cancer KOL Interview -...
November 5, 2024
HER2+ Breast Cancer KOL Interview -...
November 5, 2024
HER2+ Breast Cancer KOL Interview -...
November 5, 2024
Triple-Negative Breast Cancer (TNBC...
November 1, 2024
Triple-Negative Breast Cancer (TNBC...
November 1, 2024
Triple-Negative Breast Cancer (TNBC...
November 1, 2024
Datamonitor Healthcare Oncology: NH...
October 31, 2024
Datamonitor Healthcare Other: Uteri...
October 31, 2024
Gene, Cell, & RNA Therapy Landscape...
October 28, 2024
Datamonitor Healthcare Infectious D...
October 25, 2024
Datamonitor Healthcare CNS: Fragile...
October 25, 2024
Datamonitor Healthcare CV&Met: Sick...
October 25, 2024
Datamonitor Healthcare Infectious D...
October 23, 2024
Datamonitor Healthcare Infectious D...
October 23, 2024
Datamonitor Healthcare Infectious D...
October 23, 2024
Datamonitor Healthcare CV&Met Disea...
October 22, 2024
Datamonitor Healthcare CV&Met Disea...
October 22, 2024
Podcast: Insights from ESMO
October 21, 2024
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 11/1/24 | Novo Nordisk (NVO) | Semaglutide (NASH) for Non-Alcoholic Steatohepatitis (NASH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/31/24 | Lexicon Pharmaceuticals (LXRX) | Inpefa for Diabetes Mellitus, Type I | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/29/24 | GlycoMimetics (GLYC) | Uproleselan for Acute Myelogenous Leukemia (AML) | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/29/24 | Lexicon Pharmaceuticals (LXRX) | Inpefa for Diabetes Mellitus, Type I | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/29/24 | Shionogi (4507) | Xocova for COVID-19 Prevention | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 03/01/2025 - 04/30/2024 | Subscribers Only | Subscribers Only | Trial Announcement - Data Monitoring Board Analysis |
| 09/12/2024 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 10/16/2024 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 10/30/2024 | Subscribers Only | Subscribers Only | Progress Update - Development Review |
| 11/05/2024 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |